The Beauty Health Company - Class A Common Stock (SKIN)
1.8900
+0.3000 (18.87%)
NASDAQ · Last Trade: Aug 9th, 3:12 AM EDT
Detailed Quote
Previous Close | 1.590 |
---|---|
Open | 2.020 |
Bid | 1.900 |
Ask | 2.050 |
Day's Range | 1.770 - 2.350 |
52 Week Range | 0.7800 - 2.375 |
Volume | 7,717,968 |
Market Cap | 284.63M |
PE Ratio (TTM) | -7.560 |
EPS (TTM) | -0.3 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,082,023 |
Chart
About The Beauty Health Company - Class A Common Stock (SKIN)
The Beauty Health Co. is a dynamic company specializing in innovative skincare solutions and aesthetic technologies. Focused on enhancing beauty and wellness, the company develops and markets unique products and treatment systems that cater to both professional and consumer markets. By leveraging advanced science and cutting-edge techniques, The Beauty Health Co. aims to address various skincare needs, promoting healthier skin and boosting confidence among its users. The company's commitment to quality and innovation positions it as a leader in the rapidly evolving beauty industry. Read More
News & Press Releases
Shares of skincare company BeautyHealth (NASDAQ:SKIN)
jumped 20.6% in the morning session after the company reported second-quarter financial results that significantly beat analyst expectations on profitability and raised its full-year outlook. The company posted earnings per share of $0.03, decisively beating analyst estimates of a $0.05 loss, while revenue of $78.2 million also topped forecasts. Although total sales decreased by 13.7% compared to the previous year, investors were encouraged by a significant improvement in profitability, with adjusted EBITDA of $13.9 million significantly exceeding the consensus estimate of $3.59 million. The strong results were driven by a notable increase in gross profit margin, which expanded by 17.6 percentage points year on year. Bolstered by this performance, Beauty Health raised its full-year guidance for both net sales and adjusted EBITDA, signaling confidence in its ongoing strategy.
Via StockStory · August 8, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · August 8, 2025
U.S. stock futures rose on Friday after ending on a mixed note on Thursday. Futures of major benchmark indices were higher.
Via Benzinga · August 8, 2025
Via Benzinga · August 8, 2025
Beauty Health's stock jumped over 20% after hours as strong Q2 earnings, improved margins, and a big boost in net income beat expectations.
Via Benzinga · August 8, 2025
Skincare company BeautyHealth (NASDAQ:SKIN) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 13.7% year on year to $78.2 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $67.5 million was less impressive, coming in 2% below expectations. Its GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.
Via StockStory · August 7, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · August 7, 2025
Raises guidance on strong execution and disciplined cost management
By The Beauty Health Company · Via GlobeNewswire · August 7, 2025
Skincare company BeautyHealth (NASDAQ:SKIN)
will be announcing earnings results this Thursday after the bell. Here’s what to look for.
Via StockStory · August 5, 2025
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10.
However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.
Via StockStory · July 31, 2025
LONG BEACH, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report second quarter 2025 financial results after market close on Thursday, August 7, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.
By The Beauty Health Company · Via GlobeNewswire · July 24, 2025
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via StockStory · July 21, 2025
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. On the other hand, they usually underperform during bull runs,
and this paradigm has rung true over the past six months as the sector’s -4.1% decline paled in comparison to the S&P 500’s 7.1% gain.
Via StockStory · July 14, 2025
When Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Via StockStory · July 8, 2025
Exciting developments are taking place for the stocks in this article.
They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.
Via StockStory · July 4, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at BeautyHealth (NASDAQ:SKIN) and the best and worst performers in the personal care industry.
Via StockStory · June 23, 2025
Unprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Via StockStory · June 18, 2025
New innovation marks a breakthrough in peptide-powered, non-invasive skin health treatments to visibly address signs of aging
By The Beauty Health Company · Via GlobeNewswire · June 10, 2025
Skincare company BeautyHealth (NASDAQ:SKIN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 14.5% year on year to $69.58 million. On the other hand, next quarter’s revenue guidance of $73.5 million was less impressive, coming in 2.9% below analysts’ estimates. Its GAAP loss of $0.08 per share was 37.6% above analysts’ consensus estimates.
Via StockStory · June 10, 2025

Underscores Hydrafacial’s leadership and value to providers and consumers
By The Beauty Health Company · Via GlobeNewswire · June 4, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Via StockStory · May 28, 2025
A number of stocks jumped in the morning session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025.
Via StockStory · May 27, 2025